Latest ebit for HMHC: $250M, below the Consumer Discretionary sector average of $150B.
Get informed when a big investor buys or sells
+ FollowAs of Dec 31, 2021
Trailing 12 months ending Dec 31, 2021
The latest EBIT for HMHC is $250M as of December 2021. That compares with $-430M in the prior-year period — up 158.9% year over year. That is below the Consumer Discretionary sector average of $150B. Investors often review this figure alongside Houghton Mifflin Harcourt's historical trend and sector peers before judging valuation or financial health.
Over the past year, HMHC's EBIT moved from $-430M to $250M — a 158.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Houghton Mifflin Harcourt's operating scale or balance-sheet position.
Against Consumer Discretionary companies, HMHC currently prints $250M for EBIT, while the sector average sits near $150B. That is roughly 99.8% below the sector mean. Large gaps often invite a closer look at Houghton Mifflin Harcourt's growth, margins, and balance sheet.
A EBIT figure of $250M for HMHC is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Consumer Discretionary average is about $150B. Explore the charts below for those layers of context.
After noting HMHC's EBIT ($250M), review year-over-year change from $-430M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.